digital PCR

The company's full-year revenues rose 6 percent and were slightly higher than the consensus Wall Street estimate.

The test is for monitoring treatment response in chronic myeloid leukemia and uses a new Droplet Digital PCR instrument.

At JP Morgan, Qiagen CEO Peer Schatz discussed a new digital PCR system and handheld reader for TB testing; Qiagen's acquisition of N-of-One; and its new sample prep system.

The China-based company said that it now has 11 products that have been CE marked, and has applied for additional CE certification for other tests.

Esoterix sued Myriad in September, claiming that its myRisk Hereditary Cancer panel and services directly infringe four patents it has exclusively licensed.